⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 25, 2025International Journal of Molecular SciencesOpen Access

Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers, 3rd Edition

Andrzej Kutner G. E. Brown Enikö Kállay

View Full Paper

Ask AI

Bookmark

Share

Key Points

Effective therapies for aggressive cancers are urgently needed, impacting patient outcomes significantly.
New drug substances explored in this review could provide innovative treatment options and improve efficacy.
Novel drug carriers discussed may enhance the delivery of therapies, optimizing therapeutic effects.
Emphasis on safe and effective treatment solutions addresses vital public health demands in oncology.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

The review highlights novel therapies and drug carriers for aggressive cancers, indicating critical needs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kutner et al. (2025) studied this question.

synapsesocial.com/papers/68d7b3e2eebfec0fc5236b8e https://doi.org/10.3390/ijms26199360

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Special Issue “Novel Therapeutic Targets in Cancers: 3rd Edition”Original Research · 2026
2Recent Advances in Development of Small Molecules to Fight Cancer—Second EditionOriginal Research · 2026 · 1 citations
3Clinical Development of Novel-Novel Multi-Company Combination Therapies in Oncology.Human Clinical Trial · 2026
4Special Issue “New Molecular Mechanisms and Advanced Therapies for Solid Tumors”Original Research · 2026
5Nanocarrier-Based Strategies for Advanced Cancer Drug Delivery and Therapeutics: Design Principles, Biological Interactions, and Clinical PotentialHuman Clinical Trial · 2026 · 17 citations